Literature DB >> 8701946

Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats.

W Frankel1, A Chan, R E Corringham, S Shepherd, A Rearden, J Wang-Rodriguez.   

Abstract

Chimerism can be monitored after HLA-matched allogeneic bone marrow transplantation (BMT) or allogeneic peripheral blood stem cell transplantation (PBSCT) by detecting polymorphisms in short tandem repeats (STR). The purpose of our study was to document early complete chimerism in BMT and PBSCT recipients using STR, and to determine whether the initial WBC recovery correlated with the days required to attain complete chimerism. A total of 5 patients (2 PBSCT and 3 BMT) were followed by STR after transplantation. Peripheral blood obtained prior to transplantation was used to determine the 2 most informative STR probes for each donor/recipient pair. STR were amplified by polymerase chain reaction (PCR) with 8 commercial probes, and PCR products were visualized with silver staining. Peripheral blood was evaluated daily post-transplantation for WBC counts and to identify the presence of mixed or full chimerism by STR. The sensitivity of the STR technique varied from 0.05 to 1%, depending on the probe. Full chimerism was documented between day 9 and 14 in PBSCT recipients and on day 14 and 16 in BMT recipients. The initial rise in WBC occurred within 3 days of the onset of full chimerism, indicating that full chimerism is a more sensitive indicator of early engraftment. Periodic recipient monitoring using STR after complete chimerism identifies those patients who revert to mixed chimeras. The STR method may be useful in future studies to determine the significance of early engraftment and the clinical implications of sustained complete chimerism or mixed chimerism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8701946     DOI: 10.1002/(SICI)1096-8652(199608)52:4<281::AID-AJH7>3.0.CO;2-O

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Use of single nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis.

Authors:  D H Oliver; R E Thompson; C A Griffin; J R Eshleman
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

2.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

3.  Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms.

Authors:  Jennifer Valero-Garcia; María Del Carmen González-Espinosa; Manuel Barrios; Greta Carmona-Antoñanzas; Javier García-Planells; Carlos Ruiz-Lafora; Ainhoa Fuentes-Gálvez; Antonio Jiménez-Velasco
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

4.  Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic Malignancies.

Authors:  Mahmoud Aljurf; Hala Abalkhail; Amal Alseraihy; Said Y Mohamed; Mouhab Ayas; Fahad Alsharif; Hazza Alzahrani; Abdullah Al-Jefri; Ghuzayel Aldawsari; Ali Al-Ahmari; Asim F Belgaumi; Claudia Ulrike Walter; Hassan El-Solh; Walid Rasheed; Maher Albitar
Journal:  Biotechnol Res Int       Date:  2016-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.